Cardiorenal Actions of TRV 120027 , a Novel ß-Arrestin – Biased Ligand at the Angiotensin II Type I Receptor , in Healthy and Heart Failure Canines A Novel Therapeutic Strategy for Acute Heart Failure

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic potential of β-arrestin- and G protein-biased agonists.

  2011cited by this paper
• Acute renal failure is NOT an “acute renal success”—a clinical study on the renal oxygen supply/demand relationship in acute kidney injury

  2010cited by this paper
• Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

  2010cited by this paper
• Teaching old receptors new tricks: biasing seven-transmembrane receptors

  2010cited by this paper
• An adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo

  2009cited by this paper
• ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides.

  2008cited by this paper
• Beta-arrestin-biased ligands at seven-transmembrane receptors.

  2007cited by this paper
• Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.

  2007cited by this paper
• Targeting Heme-Oxidized Soluble Guanylate Cyclase in Experimental Heart Failure

  2007cited by this paper
• Reciprocal regulation of human soluble and particulate guanylate cyclases in vivo

  2006cited by this paper
• Cyclic Guanosine Monophosphate Compartmentation in Rat Cardiac Myocytes

  2006cited by this paper
• β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes

  2006cited by this paper
• Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice.

  2005cited by this paper
• β-Arrestin2 Is Critically Involved in CXCR4-mediated Chemotaxis, and This Is Mediated by Its Enhancement of p38 MAPK Activation*

  2002cited by this paper
• Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases.

  2001cited by this paper
• Activation and targeting of extracellular signal-regulated kinases by β-arrestin scaffolds

  2001cited by this paper
• Therapeutic actions of a new synthetic vasoactive and natriuretic peptide, dendroaspis natriuretic peptide, in experimental severe congestive heart failure.

  2001cited by this paper
• β-Arrestin 2: A Receptor-Regulated MAPK Scaffold for the Activation of JNK3

  2000cited by this paper
• Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.

  1999cited by this paper
• Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.

  1999cited by this paper
• Renal and systemic oxygen consumption in patients with normal and abnormal renal function.

  1992cited by this paper
• Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog.

  1992cited by this paper
• beta-Arrestin: a protein that regulates beta-adrenergic receptor function.

  1990cited by this paper
• Functional desensitization of the isolated beta-adrenergic receptor by the beta-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein).

  1987cited by this paper
• Further study on the two-column plasma catecholamine assay.

  1976cited by this paper
• Oxygen consumption and sodium reabsorption in the kidney.

  1961cited by this paper
• Renal sodium transport and oxygen consumption.

  1961cited by this paper
• Eine einfache colorimetrische Methode zur Inulinbestimmung für Nieren-Clearance-Untersuchungen bei Stoffwechselgesunden und Diabetikern

  1955cited by this paper
• Studies of renal oxygen consumption in man. I. The effect of tubular loading (PAH), water diuresis and osmotic (mannitol) diuresis.

  1951cited by this paper
• The oxygen consumption of the human kidney.

  1948cited by this paper

• Myogenic Vasoconstriction Requires Canonical Gq/11 Signaling of the Angiotensin II Type 1 Receptor

  2022cites this paper
• Receptors | Angiotensin Receptors

  2021cites this paper
• Receptors | Angiotensin Receptors

  2021cites this paper
• Targeting the Angiotensin II Type 1 Receptor in Cerebrovascular Diseases: Biased Signaling Raises New Hopes

  2021cites this paper
• A kinetic method for measuring agonist efficacy and ligand bias using high resolution biosensors and a kinetic data analysis framework

  2020cites this paper
• Stretch-Induced Biased Signaling in Angiotensin II Type 1 and Apelin Receptors for the Mediation of Cardiac Contractility and Hypertrophy

  2020cites this paper
• Therapeutic Potential of Targeting ß-Arrestin

  2019cites this paper
• S‐nitrosoglutathione inhibits cerebrovascular angiotensin II‐dependent and ‐independent AT1 receptor responses: A possible role of S‐nitrosation

  2019cites this paper
• Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs

  2019cites this paper
• Protein complexes as psychiatric and neurological drug targets

  2018cites this paper
• Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors

  2017cites this paper
• The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling

  2017cites this paper
• Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy

  2017cites this paper
• Current topics in angiotensin II type 1 receptor research: Focus on inverse agonism, receptor dimerization and biased agonism

  2017cites this paper
• The Renin-Angiotensin System: Is there a limit to where it goes?

  2017cites this paper
• A Systematic Approach to Identify Biased Agonists of the Apelin Receptor through High-Throughput Screening

  2017cites this paper
• AT1 receptor signaling pathways in the cardiovascular system

  2017cites this paper
• Structure-Activity Analysis of Biased Agonism at the Human Adenosine A3 Receptor

  2016cites this paper
• Recent developments in biased agonism.

  2014cites this paper
• Differential Regulation of Endosomal GPCR/β-Arrestin Complexes and Trafficking by MAPK*

  2014cites this paper
• Dynamic mass redistribution analysis of endogenous β-adrenergic receptor signaling in neonatal rat cardiac fibroblasts

  2014cites this paper
• Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure.

  2013cites this paper
• Arginine Vasopressin Enhances Cell Survival via a G Protein–Coupled Receptor Kinase 2/β-Arrestin1/Extracellular-Regulated Kinase 1/2–Dependent Pathway in H9c2 Cells

  2013cites this paper
• The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium.

  2013cites this paper
• TRV120027, a Novel &bgr;-Arrestin Biased Ligand at the Angiotensin II Type I Receptor, Unloads the Heart and Maintains Renal Function When Added to Furosemide in Experimental Heart Failure

  2012cites this paper
• Differential β-Arrestin–Dependent Conformational Signaling and Cellular Responses Revealed by Angiotensin Analogs

  2012cites this paper